Product Dossier
ESTROFEM
Product Dossier for ESTROFEM (estradiol, Novo Nordisk Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Novo Nordisk Pharmaceuticals
- Active ingredient: estradiol
- Therapeutic area: Reproductive Health
- Related brand: ESTRADOT
- Related brand: Estraderm MX
- Related brand: FEMOSTON
- Same area: PROVERA
- Same area: BEMFOLA
What it is
Estrofem is an estradiol (as hemihydrate) tablet product sponsored by Novo Nordisk Pharmaceuticals.
Approved indications
No information regarding approved indications is available in the provided source documents.
Dosing overview
No information regarding dosing is available in the provided source documents.
Key safety warnings
No information regarding safety warnings is available in the provided source documents.
Contraindications
No information regarding contraindications is available in the provided source documents.
PBS listing
No information regarding PBS listing is available in the provided source documents.
Regulatory history
Estrofem was first registered on the ARTG on 17 November 2011. Two strengths are registered: a 1 mg tablet dial dispenser pack and a 2 mg tablet dial dispenser pack.